Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Britain will study whether the use of Eli Lilly’s weight loss drug can get people back into work and help tackle the high ...

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...

The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use ...

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...